Ranibizumab is not bevacizumab for retinal vein occlusions

被引:0
|
作者
Roberto Gallego-Pinazo
Rosa Dolz-Marco
Manuel Díaz-Llopis
机构
[1] University and Polytechnic Hospital La Fe,Unit of Macula. Department of Ophthalmology
[2] University of Valencia,Faculty of Medicine
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:955 / 956
页数:1
相关论文
共 50 条
  • [21] Retinal vein occlusions
    Pierru, A.
    Girmens, J. -F.
    Heron, E.
    Paques, M.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2017, 40 (08): : 696 - 705
  • [22] Comparison of ranibizumab and bevacizumab pro re nata therapy for retinal vein occlusion
    Yamada, Rika
    Nishida, Akihiro
    Shimozono, Masataka
    Kameda, Takanori
    Miyamoto, Noriko
    Mandai, Michiko
    Kurimoto, Yasuo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [23] Recurrence of macular edema in retinal vein occlusions after treatment with intravitreal ranibizumab (Lucentis)
    Karagiannis, Dimitrios A.
    Karampelas, Michael D.
    Soumplis, Vasileios M.
    Amariotakis, Christos
    Georgalas, Ilias
    Kandarakis, Artemios
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2011, 46 (06): : 486 - 490
  • [24] Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusions in Patients with Previous Uneffective Treatments
    Esposito, Fernando
    Chandran, Manju
    Menon, Geeta
    OPHTHALMOLOGICA, 2014, 232 : 93 - 93
  • [25] The Prognostic Role of Microcystic Macular Changes in Patients with Retinal Vein Occlusions Treated with Ranibizumab
    Rehak, Matus
    Tuisl, Maria
    Wiedemann, Peter M. H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [26] Ranibizumab for macular edema due to retinal vein occlusions: Implication of VEGF as a critical stimulator
    Campochiaro, Peter A.
    Hafiz, Gulnar
    Shah, Syed Mahmood
    Nguyen, Quan Dong
    Ying, Howard
    Do, Diana V.
    Quinlan, Edward
    Zimmer-Galler, Ingrid
    Haller, Julia A.
    Solomon, Sharon D.
    Sung, Jennifer U.
    Hadi, Yasmin
    Janjua, Kashif A.
    Jawed, Nida
    Choy, David F.
    Arron, Joseph R.
    MOLECULAR THERAPY, 2008, 16 (04) : 791 - 799
  • [27] The Impact of Race on the Efficacy of Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusions
    Osathanugrah, Pawarissara
    Prasad, Minali
    Sanjiv, Nayan
    Ness, Steven
    Siegel, Nicole H.
    Chen, Xuejing
    Subramanian, Manju L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [28] Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions - IBeVO study
    Costa, Rogerio A.
    Jorge, Rodrigo
    Calucci, Daniela
    Melo, Luiz A., Jr.
    Cardillo, Jose A.
    Scott, Ingrid U.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (02): : 141 - 149
  • [29] Comparison of intravitreal ranibizumab and bevacizumab for the treatment of macular edema secondary to retinal vein occlusion
    Alex Yuan
    Baseer U.Ahmad
    David Xu
    Rishi P.Singh
    Peter K.Kaiser
    Daniel F.Martin
    Jonathan E.Sears
    Andrew P.Schachat
    Justis P.Ehlers
    International Journal of Ophthalmology, 2014, 7 (01) : 86 - 91
  • [30] Comparison of intravitreal ranibizumab and bevacizumab for the treatment of macular edema secondary to retinal vein occlusion
    Yuan, Alex
    Ahmad, Baseer U.
    Xu, David
    Singh, Rishi P.
    Kaiser, Peter K.
    Martin, Daniel F.
    Sears, Jonathan E.
    Schachat, Andrew P.
    Ehlers, Justis P.
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2014, 7 (01) : 86 - 91